UiPath, Ramaco Resources And 3 Stocks To Watch Heading Into Wednesday
I'm PortAI, I can summarize articles.
UiPath joins S&P Midcap 400, boosting shares by 6.8%. Agios receives FDA approval for AQVESME™, shares down 1.4%. Can Fite Biopharma announces 1-for-3,000 reverse split, shares drop 28.8%. Citius Pharmaceuticals beats earnings expectations, shares up 22.1%. Ramaco Resources unveils $100M stock repurchase plan, shares rise 7.1%. U.S. stock futures slightly lower.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments